Background: Ras-mediated transformation of mammalian cells has been shown to activate multiple signalling pathways, including those involving mitogen-activated protein kinases and the small GTPase Rho. Members of the Rho family affect cell morphology by controlling the formation of actindependent structures: specifically, filopodia are induced by Cdc42Hs, lamellipodia and ruffles by Rac, and stress fibers by RhoA. In addition, Rho GTPases are involved in progression through the G1 phase of the cell cycle, and Rac1 and RhoA have recently been directly implicated in the morphogenic and mitogenic responses to transformation by oncogenic Ras. In order to examine the cross-talk between Ras and Rho proteins, we investigated the effects on focus-forming activity and cell growth of the Rho-family members Cdc42Hs, Rac1 and RhoG by expressing constitutively active or dominantnegative forms in NIH3T3 cells.
Background
In mammalian cells, the expression of oncogenic Ras proteins has been shown to activate mitogenesis, as well as to cause extensive changes in cell morphology. Activation of mitogenesis relies on the pathways involving Raf, Mek and the extracellular signal regulated kinases (ERKs, also called mitogen-activated protein or MAP kinases), the individual components of which have also been described as capable of transforming cells [1] . Analysis of Ras mutants impaired in binding to Raf has revealed that Rasinduced transformation requires the activation of the Raf pathway, and also of two Raf-independent pathways, at least one of which is Rho-dependent [2, 3] .
Members of the Rho family of small GTPases have been implicated in the signal transduction pathways involved in the control of cell morphology and motile activity. The Rho family includes Rho (A, B, C), RhoE, RhoL, Rac (1 and 2), RhoG, Cdc42Hs and TC10 [4] [5] [6] [7] [8] [9] . In fibroblastic cells, Cdc42Hs regulates the formation of filopodia, Rac the formation of membrane ruffles and lamellipodia, and Rho the formation of focal adhesion plaques and actin stress fibres [10] [11] [12] [13] [14] [15] . More recently, Rho family members have also been shown to be essential for cell growth: RhoA, Rac1 and Cdc42Hs promote cell cycle progression through the G1 phase, up to the point of S phase entry [16] . Furthermore, three other Rho family members have been shown to be encoded by genes activated upon extracellular signal stimulation: Rac2, a hemopoietic lineagespecific GTPase closely related to Rac1 [17] ; RhoB, which is closely related to RhoA and encoded by an immediateearly growth response gene [18] ; and RhoG, which is related to Rac1 and Cdc42Hs, and whose mRNA accumulates during the late G1 phase in growth-stimulated fibroblasts [9] . In addition, Cdc42Hs and Rac1 activate the Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) [19, 20] , leading to subsequent gene activation driven by the serum response factor (SRF) [21] .
Further evidence for a role of Rho family members in Rasmediated transformation was provided by the observation that dominant-negative mutants of Rac1, RhoA and RhoB inhibit Ras-induced transformation [22] [23] [24] [25] . Activated versions of these proteins have a low transforming potential, eliciting foci that are morphologically distinct from those induced by Ras and are formed of aggregates of nonrefractile, piled-up cells. Foci of similar morphology are also produced -at a higher frequency -by the oncogenic versions of guanine exchange factors (GEFs), such as Vav or Dbl, that act on Rho family members [26] . In the present study, we investigated the effects of RhoG protein, containing either an activating or an inhibitory mutation, on cell proliferation and on Ras-mediated and Raf-mediated transformation, as well as the relationships of RhoG with Rac1 and Cdc42Hs.
Results

Activation of RhoG and Rac1 but not Cdc42Hs increases cell saturation density
It was recently reported that cells expressing constitutively active Rac1, which contains a valine substitution at position 12 (Rac1-V12), grew at a higher saturation density than normal cells as a result of a partial loss of contact inhibition [25] . In order to compare the effects of RhoG, Rac and Cdc42Hs, we produced retroviruses directing the expression of activated (V12) and inhibitory (N17) RhoG proteins tagged with the hemagglutinin epitope (HA), and Rac1 and Cdc42Hs proteins tagged with the Myc epitope, and used them to infect NIH3T3 cells. The specificity of the N17 dominant-negative forms of Rac1 and Cdc42Hs was previously demonstrated by their effects on the Rac-dependent membrane ruffling induced by epidermal growth factor (EGF), the Cdc42Hs-dependent induction of filopodia by bradykinin, and the RhoA-dependent stress fiber formation induced by lysophosphatidic acid (LPA). Using a similar approach, we showed that expression of RhoG-N17 did not impair the formation of ruffles, filopodia or stress fibers (data not shown). An extensive study of the actin structure and morphology of fibroblasts expressing activated and dominant-negative RhoG will be described elsewhere (C.G-R., unpublished observations).
Expression of the retrovirally expressed proteins was monitored by western blotting (Figure 1a) . Expression of RhoG-V12 led to an overall increased proliferation of the infected cells (Figure 1b) . Time-course analysis indicated that the infected cells displayed a slightly longer doubling time but grew at a higher saturation density (60% increase) than NIH3T3 control cells infected with wildtype pLXSN particles (Table 1) . Conversely, cells expressing RhoG-N17 had an increased doubling time during the first day, then grew at the same rate as control cells, and stopped growing at a 45% lower saturation density (Figure 1b) . The use of 20-fold and 200-fold higher viral particle concentrations for the infection elicited a 4-fold and 11-fold increase in RhoG-N17 expression (Figure 1a) , which led to a further 10% and 50%
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Figure 1
Changes in cell saturation density upon expression of RhoG, Rac1 or Cdc42Hs. (a) NIH3T3 cells (10 5 ) were infected with 10 5 colony forming units (cfu) pLXSN wild-type particles (C1, C2 and C3) or particles expressing HA-tagged RhoG-V12 or RhoG-N17, or Myc-tagged Cdc42Hs-V12, Cdc42Hs-N17, Rac1-V12 or Rac1-N17. Total proteins from infected cells (40 µg) were analysed by gel electrophoresis followed by western blotting with 12CA5 anti-HA and 9E10 anti-Myc monoclonal antibodies. The increase in RhoG-N17 protein expression in cells infected with 2 × 10 6 cfu (20x RhoG-N17) and 2 × reduction of the saturation density, respectively ( Figure  1b) . Identical results were observed using NIH3T3 cells stably transfected with plasmid DNA directing the expression of the same mutant RhoG proteins, indicating that the observed effects were independent of the expression procedure. Expression of Rac1-V12 led to a 90% increase in the cell density at the plateau, whereas expression of Rac1-N17 led to a 40-45% drop in cell density (Figure 1c ), in agreement with previously published data [25] . In contrast, Cdc42Hs-V12 expression led to a very limited effect (less than 10%), whereas a 40-45% drop in cell density was observed upon Cdc42Hs-N17 expression, which is within the range of the effects observed using RhoG and Rac1.
Focus formation induced by Ras-V12 requires and is potentiated by RhoG, Rac1 and Cdc42Hs activity
We next examined the role of RhoG, Rac1 and Cdc42Hs in focus formation by NIH3T3 cells, using transfection and retroviral infection procedures. Rac activity has previously been shown to be insufficient to promote focus formation but necessary for Ras-induced transformation [23, 25] . We therefore investigated whether RhoG and Cdc42Hs had similar properties. Transfected Ras-V12 alone produced approximately 5 × 10 3 transformed foci per µg of transfected DNA (corresponding to 100% in Figure   2 ), which is within the range of previously published data [23, 25, 27] . RhoG-V12, Rac1-V12 and Cdc42Hs-V12 had very little intrinsic focus-forming activity, if any (less than four transformed foci per µg transfected DNA). Cotransfection of 2 ng of vector encoding Ras-V12 with vectors encoding the activated versions of RhoG, Rac1 or Cdc42Hs (50 ng or 500 ng) led to a two-fold, four-fold and three-fold increase in the number of foci, respectively, indicating a cooperative effect of each Rho GTPase with Ras-V12. The cooperation was particularly efficient with Rac1-V12, which required a DNA input 10-fold lower than
RhoG-V12 and Cdc42Hs-V12. On the other hand, coexpression of the N17 dominant-negative mutant forms led to a 50% (RhoG), 60% (Cdc42Hs) or 80% (Rac1) decrease in the number of foci, indicating that the activity of each GTPase is required for focus formation mediated by Ras-V12. The values obtained for both Rac1 mutants are within the range of published results [23, 25] .
Cdc42Hs, RhoG and Rac1 cooperate in focus formation
The preceding results suggested that RhoG, Rac1 and Cdc42Hs might mediate several Ras-V12-dependent pathways that lead to focus formation. This notion is supported by the oncogenic potential of many GEFs that activate several members of the Rho family [15, [28] [29] [30] [31] [32] . In order to determine whether RhoG, Rac1 and Cdc42Hs might activate distinct cooperative pathways, we first Effects of activated and dominant-negative forms of RhoG, Rac1 and Cdc42Hs on Ras-V12 focus-forming activity. NIH 3T3 cells (10 5 ) were either transfected with 500 ng vector expressing RhoG-V12, Cdc42Hs-V12 or Rac1-V12, or cotransfected with 1 µg DNA containing 2 ng pECEG12V-ras (encoding Ras-V12) and 50 ng or 500 ng of construct expressing RhoG-V12, Cdc42Hs-V12 or Rac1-V12, or 1µg plasmid DNA expressing the dominant-negative forms. Empty pCDNA3 was used as a negative control. After the cells reached confluence, each culture was split into four dishes and the concentration of fetal calf serum was reduced from 10% to 4%. The number of foci was scored 14 days later, and is expressed as a proportion of the foci induced by Ras-V12 (100%). The mean of two independent assays done in triplicate is shown; error bars indicate the SEM. RhoG-V12 (500 ng) Rac1-V12 (50 ng) Rac1-V12 (500 ng) Cdc42Hs-V12 (50 ng) Cdc42Hs-V12 (500 ng) RhoG-N17 (1
µg)
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Cdc42Hs-N17 (1 µg) performed focus formation assays on NIH3T3 cells concomitantly expressing the three activated RhoG, Rac1 and Cdc42Hs mutants ( Figure 3 ). For these assays, 50 ng expression plasmid was used, a DNA input at which very low or no focus-forming activity was observed for each construct (see Figure 2) . Coexpression of all three Rho GTPases led to an average of ~10 3 foci per µg of input DNA -that is, about 20% of Ras-V12 activity and more than two orders of magnitude higher than the focus-forming activity elicited by each GTPase alone. This prompted us to examine the effects of pairwise combinations.
Using the same amounts of each DNA (50 ng), coexpression of RhoG-V12 and Rac1-V12, RhoG-V12 and Cdc42Hs-V12, and Rac1-V12 and Cdc42Hs-V12 led to an average of 35, 80 and 480 foci per µg input DNA, respectively. Cdc42Hs-V12 with Rac1-V12 therefore represents the most efficient combination (giving up to 10% of Ras-V12 focus-forming activity), suggesting that the two GTPases control cooperative pathways, in agreement with their differential effects on contact inhibition. Conversely, the combination of RhoG-V12 and Rac1-V12, both of which decrease contact inhibition, had the lowest focusforming activity, suggesting that these GTPases control some pathways in common. To address this latter issue, we coexpressed each pair of activated GTPases with the dominant-negative version of the third one (grey boxes, Figure 3 ). Expression of Rac-N17 led to a significant inhibition (up to 80%) of the focus-forming activity of Cdc42Hs-V12 plus RhoG-V12, whereas RhoG-N17 only partially reduced the number of foci elicited by Rac-V12 plus Cdc42Hs-V12. Although these data might fit several regulatory schemes, they rather suggest that the endogenous Rac1 protein might control an essential step downstream of RhoG-V12 and Cdc42Hs-V12. In contrast, expression of Cdc42Hs-N17 did not reduce the focusforming activity of Rac1-V12 plus RhoG-V12, indicating that the action of these two GTPases is independent of endogenous Cdc42Hs.
Focus formation mediated by Cdc42Hs, RhoG and Rac1 uses pathways distinct from the Raf/Mek/ERK pathway
Activation of the ERK pathway by the translocation and phosphorylation of cellular Raf-1 has long been known to be necessary for cell transformation mediated by Ras-V12 [33, 34] . We thus investigated the relationships between the ERK pathway and the pathways controlled by Cdc42Hs, RhoG and Rac1. We first examined the effect of the activated and inhibitory forms of RhoG, Rac1 and Cdc42Hs on focus formation in NIH3T3 cells expressing v-Raf, the viral oncogenic form of cellular Raf-1. The average number of foci produced by v-Raf alone was about 10 2 per µg transfected DNA (indicated as 100% in Figure  4a ), which corresponds to 2-5% of the number obtained with Ras-V12 (see Figure 3) . Coexpression of v-Raf and the inhibitory forms of RhoG, Rac1 and Cdc42Hs did not reduce the number of foci. Conversely, coexpression of v-Raf with Rac1-V12 and RhoG-V12 elicited a three-fold to eight-fold increase in the foci number. The increase observed for Rac1 is within the range of previously published data [25] . RhoG requires a higher DNA input for cooperating with Ras-V12 and v-Raf, a feature that might reflect a difference in protein level or activity. Interestingly, coexpression of Cdc42Hs-N17 or Cdc42Hs-V12 had no effect on Raf transformation, a finding which further strengthens the notion that Cdc42Hs controls pathways distinct from RhoG and Rac1.
Although the endogenous activity of RhoG, Rac1 and Cdc42Hs GTPases is not crucial for transformation mediated by v-Raf, each of them is necessary for transformation mediated by Ras-V12, suggesting that signal transduction from Ras to Raf might be affected by Rho-dependent pathways. To address this issue, we examined the effects of RhoG, Rac1 and Cdc42Hs on the activity of the MAP kinase ERK2, activation of which is triggered by Raf. Coexpression of HA-tagged forms of ERK2 and the mutated forms of either RhoG, Rac1 or Cdc42Hs was 
achieved by transient cotransfection of NIH3T3 cells, and kinase activity was assayed after immunoprecipitation using an anti-HA antibody. As observed in Figure 4b , expression of the N17-mutated GTPases did not reduced Ras-V12-mediated ERK2 activation, demonstrating that the inhibitory effect of the N17 GTPases is not correlated with an impairment of Raf activation. Instead, we observed a two-fold to three-fold induction of the activity of the exogenous ERK2 upon expression of Rac1-N17 and RhoG-N17, suggesting that inhibition of either of the GTPases might increase the Ras/Raf signalling or decrease its downregulation.
We next investigated the effect of the activated GTPases on ERK2 activation (Figure 4c) . Expression of any of the three GTPases had no significant effect on ERK2 activation in resting cells. Thus, the cooperative effect of RhoG-V12 and Rac1-V12 with v-Raf is not mediated by an increase in ERK2 activity. Besides, coexpression of any combination of the V12-GTPases failed to activate ERK2, indicating that the high focus-forming activity elicited by the coordinate activation of Cdc42Hs, RhoG and Rac1 is independent of ERK2 activation. Similarly, no change in ERK2 activity was detected in foci generated from the combination of RhoG-V12, Rac1-V12 and Cdc42Hs-V12 (data not shown).
Constitutively active RhoG, Rac1 and Cdc42Hs do not cooperate to activate the JNK pathway
Activation of Rac1 and Cdc42Hs has been previously reported to activate the JNK pathway but to have no effect on the ERK2 pathway [19, 20, 35] . In order to determine whether the focus formation controlled by the interaction of Cdc42Hs and RhoG or Rac1 could be associated with a quantitative change in JNK activity, we performed the experiments presented in Figure 5 . We first checked whether Ras-V12-mediated JNK activation was dependent on RhoG, Rac1 and Cdc42Hs activity. NIH3T3 cells were transiently cotransfected to express HA-tagged versions of JNK and each of the inhibitory versions of RhoG, Rac1 or Cdc42Hs. As shown in Figure 5a , expression of either one of the mutated GTPases prevented the Rasmediated JNK activation, as has been described previously for Rac1 and Cdc42Hs [19, 20] . We next analysed the effect of expressing the activated GTPases, either alone or in combination (Figure 5b ). Cdc42Hs-V12 and Rac1-V12 led to a 17-fold and a 6-fold increase in JNK activity, respectively, in agreement with previous reports [19, 20] . Expression of RhoG-V12 led to an 8-fold increase, which is within the range of that elicited by Rac1-V12. When different combinations were used, however, the effects on JNK activity were not additive: the resulting JNK activity was identical to that induced by the most potent GTPase used in the combination. This indicates that no major change in JNK activation is associated with the focus-forming activity elicited by the association of Cdc42Hs, Rac1 and RhoG. Similar levels of JNK activity were observed in cells derived from foci generated from the coexpression of the three V12-GTPases (data not shown).
Discussion
Several reports have implicated Rho family members in the processes of cell proliferation and transformation. First, Rac1, Cdc42Hs and RhoA are required for cell cycle progression from G0 through to the G1 phase [16] and modulate transcriptional activity mediated by SRF [21] . In addition, Rac1 and Cdc42Hs activate the JNK pathway, inducing changes in the pattern of gene transcription [19, 20, 35] . Second, the members of the Dbl family of oncogenes all contain a common domain that stimulates GDP-GTP exchange for Rho GTPases and is necessary for the oncogenic properties of the Dbl family [15, 29] . And third, Ras-induced, but not Raf-induced, transformation is blocked by the expression of dominantnegative mutants of Rac1, RhoA and RhoB, whereas expression of constitutively active Rac1 or RhoA acts synergistically with activated Raf to transform cells [22] [23] [24] [25] .
In this study, we investigated the contributions of Cdc42Hs and RhoG to the control of cell proliferation and transformation, as well as their regulatory cross-talks with Rac1, Ras and Raf.
Our data showed that activation of RhoG led to a modulation of cell saturation density, as has previously been shown for Rac1 [25] . This might account for the low cooperativity in focus formation displayed by these two GTPases when expressed together, and might suggest that they are involved in a common pathway controlling cell contact inhibition. RhoG might act usptream of Rac1, as expression of RhoG-N17 has little effect on the focusforming activity of Rac1/Cdc42Hs, whereas Rac1-N17 inhibits the focus-forming activity of RhoG/Cdc42Hs. This suggestion agrees well with our unpublished results showing that RhoG requires endogenous Rac1 activity to elicit ruffling in Swiss 3T3 cells (C.G-R., unpublished observations). The case for Rac1 being downstream of RhoG is further strengthened by the observation that dominant-negative Rac1 is the most potent inhibitor of Ras-V12-mediated transformation. The failure of RhoG and Rac1 to elicit focus formation is consistent with the results of Tiam1 characterizations. Tiam1 is an exchange factor for Rac1, and oncogenic versions of Tiam1 elicit tumours with a high invasive and metastatic potential [15] . Tiam1 was shown to induce relatively dense areas of epithelium-like cells that grew as monolayers [30] , indicating that although Rac1 activation leads to a reduction in contact inhibition, additional signals are required for the formation of multilayers by NIH3T3 cells. Such signals might be mediated through Cdc42Hs, which delineates a distinct pathway, as it has no effect on saturation density and promotes focus-forming activity when coexpressed with Rac1, reaching 10% of the activity of Ras-V12. A third pathway might be controlled by RhoA, which was previously reported to be involved in Ras-mediated transformation: although it has a very low transforming potential on its own, RhoA strongly cooperates with weakly transforming Raf mutants, and expression of dominantnegative RhoA-N19 reverts Ras-mediated transformation [23, 25] . Cooperativity between Rho GTPases in focus formation is in keeping with the densely packed morphology of foci induced by exchange factors such as Dbl, Vav, Ect2 or Ost, which might act simultaneously on distinct GTPases [26, 28, 32, 36] .
Interestingly, the focus-forming activity elicited by the association of RhoG, Rac1 and Cdc42Hs uses pathways independent of the ERK2 and JNK MAP kinases. JNK activity is enhanced in cells expressing Cdc42Hs-V12 or Rac1-V12, as previously reported [16, 19, 20] , and we have shown that this is also the case for RhoG-V12. However, no increase in JNK activity was detected in cells expressing any focus-forming combination of GTPases when compared to cells expressing only Cdc42Hs, the most potent JNK activator. This is in agreement with the finding that JNK activation is not required for Rac-induced proliferation, for G1 cell cycle progression induced by Rac or Cdc42, or for actin polymerization [37, 38] . Ras-dependent transformation was shown to be impaired upon inhibition of the activity of ERK1 or ERK2 [23] or Mek [1, 39] . Nevertheless, a doubly mutated Ras (Glu12→Val, Thr35→Ser) was reported to be defective for its transforming properties, although it could nevertheless activate the ERK cascade and stimulate SRE-dependent gene transcription [2] . Our own data show that inhibition of Cdc42Hs, Rac1 or RhoG decreases Ras-mediated transformation without any inhibition of ERK2 activation. Conversely, the coordinated activation of Rac1, RhoG and Cdc42Hs gives a high focus-forming activity without any change in ERK2 activation. The resulting foci have a morphology distinct from Ras-V12-transformed cells, however, suggesting that activation of the Raf/Mek/ERK2 pathway is required, in addition to Rho pathways, to produce a fully transformed phenotype.
Conclusions
Our present analysis shows that coordinated activation of the Cdc42Hs, Rac1 and RhoG GTPases elicited a high focus-forming activity in NIH3T3 cells, whereas expression of each of them alone failed to induce foci. This effect of coordinated activation cannot be explained by the regulatory linear cascade proposed for actin-dependent cytoskeletal reorganisation in Swiss 3T3 cells, in which Cdc42Hs activation was shown to activate Rac1 which in turn activates RhoA [10] [11] [12] [13] 16] . We propose that additional pathways, independent of the ERK2 and JNK kinases, are involved in the process of focus formation. One pathway modulates cell contact inhibition and is governed by Rac1 and, to a lesser extent, RhoG. A second pathway, acting independently, is controlled by Cdc42Hs. Detailed analysis of the morphological changes induced in the 'Rho-like' foci, as well as knowledge of the cross-talks between RhoA and the RhoG/Rac1/Cdc42Hs GTPases, are now required, in order to determine which additional pathways are involved and what impact they have on the process of focus formation.
Materials and methods
DNA constructs and site directed mutagenesis
The wild-type RhoG open reading frame (ORF) was amplified using the polymerase chain reaction (PCR) and the amplimers 5′-dCG-GAATTCATGCAGAGCATCAAGTG-3′ and 5′-dGCTCTAGAGGTCA-CAAGAGGATGCA-3′; PCR products were cloned into the EcoR1 and Xba1 sites of pT7T318U (Pharmacia). Mutated ORFs (Gly12→Val and Thr17→Asn) were generated by site-directed mutagenesis of uridylated phagemid single-stranded DNA, as described by Wang et al. [40] using the oligonucleotides 5′-dCTTGCCCACAGCGACGTCACCCACCACp-3′ (Gly12→Val), 5′-dGCAGGCAATTCTTGCCCACAGCGCCGTCACCp-3′ (Thr17→Asn) and 5'-dCGAACACGGCCGGGATGTACTCp-3′ (Thr35→Ala). The presence of mutations was checked by DNA sequencing. The mutated ORFs were subcloned into the EcoRI and XbaI sites of pCDFT [41] , a derivative of pCDNA3 allowing expression of HA-tagged proteins, to give pCDNA-rhoG-V12, and pCDNA-rhoG-N17.
To express HA-tagged RhoG proteins by retroviral infection, the oligonucleotide 5′-dAATTGCCACCATGTATGATGTTCCTGATTATG-CTAGCCTCGAATTCAAC-3′ encoding the HA epitope was inserted into pLXSN, a MoMuLV-derived vector expressing resistance to the drug G418, giving pLXSN-HA. RhoG mutated ORFs were then subcloned into the EcoRI and SalI sites of pLXSN-HA, to give pLXSNRhoG-V12 and pLXSN-RhoG-N17. The ORFs encoding Myc-epitope tagged mutated versions of Rac1 and Cdc42Hs were excised from pMT90-derived constructs (kindly provided by Philippe Chavrier, CIML, Marseille) and subcloned into a pLXSN-derived vector, containing a NotI site instead of its HpaI site, to give pLXSN-Cdc42HS-V12, pLXSN-Cdc42HS-N17, pLXSN-Rac1-V12 and pLXSN-Rac1-N17.
Cell culture and retroviral particle production
NIH3T3 and virus producer GP+E-86 were cultured in 4.5 g/l Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal calf serum (FCS; Bio Media) at 37°C in a humidified atmosphere (95% air; 5% CO 2 ). Transfections into GP+E-86 cells were performed using the Lipofectamin method, as recommended by the supplier (Gibco-BRL). Neomycin-resistant clones were selected with 600µg/ml G418 and then pooled. Ecotropic retroviral particles were prepared by harvesting 10 ml normal medium, applied 18 h previously, from a confluent monolayer of a 100 mm dish of GP+E-86 virus-producing cells and then filtering the medium through a 0.45 µm filter (Millipore). To estimate retroviral titers, NIH3T3 cells were infected by incubating a 100 mm plate containing 5 × 10 5 cells with 2 ml viral supernatant, or a dilution thereof, in the presence of 5 µg/ml Polybrene (Aldrich) for 5 h. Medium (8 ml) was added and the cells were then grown to confluence for 2 days before being split into selective medium (600 g/ml G418). After 10 days of selection, the resistant colonies were counted and retroviral titers were expressed as the number of colony forming units (cfu) per ml retroviral medium.
Focus formation assay
Briefly, 10 5 NIH3T3 cells were cotransfected with 1 g total DNA containing different combinations of vectors expressing Ras-V12, v-Raf or the mutated versions of RhoG, Rac and Cdc42Hs, using lipofection (8µl Lipofectamin in 800 l OptiMEM (Gibco-BRL) for 5 h) on 6 cm dishes. Alternatively, cells were first transfected then, 24 h later, infected overnight with retroviral particles (2 × 10 5 cfu) expressing the different mutant forms of RhoG, Rac1 and Cdc42Hs in the presence of 5g/ml Polybrene. After cells reached confluency, each 6 cm dish was split into four 6 cm diameter dishes and the FCS concentration was reduced from 10% to 4%. Medium was changed every 2.5 days. Cells were fixed 12-14 days later and stained with a solution containing 30% methanol and 0.4% crystal violet. Foci larger than 1 mm in diameter were scored.
MAP kinase assays
NIH3T3 cells (5 × 10 5 ) were seeded into each well of six-well plates. Cells were transfected 18 h later with 0.5 µg of each plasmid DNA, expressing either HA-JNK1 (pSRα.3HA.JNK1) or HA-ERK2 (pECEHAp44MAPK) and the small GTPases to be tested, using 4µl Lipofectamin for 5 h in OptiMEM. Cells were then left for 24 h in DMEM without serum and harvested in Triton Lysis Buffer (TLB) containing 20 mM Tris-HCl (pH 7.5), 137 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1 mM β-glycerophosphate, 1 mM sodium orthovanadate, 10% glycerol, 1 mM PMSF and 10 µg/ml leupeptin. Soluble extracts were prepared by centrifugation at 15,000 rpm for 30 min at 4°C. Extracts were separated into 2 fractions: the first one to test the expression of the tagged MAP kinase and of the transfected small GTPases, and the second to assay for ERK2 or JNK activities as follows: extracts were incubated with 5µl anti-HA monoclonal antibody 12CA5 pre-bound to 20l protein-GSepharose (Pharmacia). After a 2 h incubation at 4°C, the immunoprecipitates were washed three times with TLB and twice with kinase buffer containing 25 mM Hepes (pH 7.5), 25 mM MgCl 2 , 25 mM β-glycerophosphate, 2 mM DTT and 0.1 mM sodium orthovanadate. Immunocomplex kinase assays were performed at 30°C for 30 min using 4µg substrate (myelin basic protein (Sigma) for ERK2 activities, and GST-cJun(1-79) for JNK activities), 50 µM ATP and 10 µCi γ-[ 32 P]ATP in 20 µl kinase buffer. The reactions were stopped with Laemmli sample buffer and the products were resolved by gel electrophoresis (10% polyacrylamide gels for JNK assays and 15% polyacrylamide gels for ERK2 assays). Dried gels were exposed on imaging plates for 1 h, and signals were quantified with a phosphorimager (Molecular Dynamics).
